Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

CMS adds office to review regulatory and administrative burdens

CMS has announced the formation of the Office of the Burden Reduction and Health Informatics, an organized effort to reduce regulatory and administrative burden and part of the agency’s Patients over Paperwork initiative.

Thumbnail

CMS proposes value-based payment on prescription drugs

CMS has proposed a new rule that aims to enable value-based purchasing agreements across states with drug companies to bring down Medicaid drug prices.

Thumbnail

Walmart acquires health management app CareZone

Walmart has expanded its digital health services by acquiring CareZone, a technology platform and mobile app that allows individuals and families to manage medicine and chronic disease.

Thumbnail

Physicians estimate return to normal in August 2021

It will be more than a year for the U.S. healthcare industry to return to normal, with physicians expecting the new normal to be sometime around August 2021once a vaccine for COVID-19 has been distributed.

Thumbnail

HHS finalizes rule repealing Obama-era protections for trans patients

The rule eliminates provisions of a 2016 rule from the Obama administration that attempted to protect trans patients from discrimination.

Thumbnail

Kaiser Permanente to return $500M in coronavirus aid

Kaiser Permanente is among a handful of major healthcare organizations that have promised to refund the government millions in aid meant to help health systems and hospitals deal with the COVID-19 pandemic.

Cost of coronavirus tests varies, but high costs are exceptions

Reports of sky-high costs for coronavirus testing may be the exception, with the majority of testing being “relatively tame” in cost, according to an analysis by Axios.

Thumbnail

Trump promises to break US away from WHO

President Trump has stated he wants to terminate the United States’ relationship with the World Health Organization.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.